Pl. Brubaker et al., REGULATION OF GLUCAGON-LIKE PEPTIDE-1 SYNTHESIS AND SECRETION IN THE GLUTAG ENTEROENDOCRINE CELL-LINE, Endocrinology, 139(10), 1998, pp. 4108-4114
Glucagon-like peptide-1 (GLP-1) released from the intestine is a poten
t stimulator of glucose-dependent insulin secretion. To elucidate the
factors regulating GLP-1 secretion, we have studied the enteroendocrin
e GLUTag cell line. GLP-1 secretion was stimulated in a dose-dependent
fashion by activation of protein kinase A or C with forskolin or phor
bol 12,13-dibutyrate, respectively (by 2.3 +/- 0.5-fold at 100 mu M an
d 4.3 +/- 0.6-fold at 0.3 mu M, respectively; P < 0.01-0.001). Of the
regulatory peptides tested, only glucose-dependent insulinotropic pept
ide stimulated the release of GLP-1 (by 2.3 +/- 0.2-fold at 0.1 mu M;
P < 0.001); glucagon was without effect, and paradoxically, the inhibi
tory neuropeptide somatostatin-14 increased secretion slightly (by 1.6
+/- 0.3-fold at 0.01 mu M; P < 0.05). In tests of several neurotransm
itters, only the cholinergic agonists carbachol and bethanechol stimul
ated peptide secretion in a dose-dependent fashion (by 2.3 +/- 0.5- an
d 1.7 +/- 0.3-fold at 1000 mu M; P < 0.06-0.001); the beta-adrenergic
agonist isoproterenol and the chloride channel inhibitor gamma-aminobu
tyric acid did not affect release of GLP-1. Long chain monounsaturated
fatty acids (18:1), but not saturated fatty acids (16:0), also stimul
ated the release of GLP-1 (by 1.7 +/- 0.1-fold at 150 mu M; P < 0.001)
. Consistent with the presence of a cAMP response element in the progl
ucagon gene, activation of the protein kinase A-dependent pathway with
forskolin increased proglucagon messenger RNA transcript levels by 2-
fold (P < 0.05); glucose-dependent insulinotropic peptide and phorbol
12,13-dibutyrate were without effect. Therefore, by comparison with re
sults obtained using primary L cell cultures or in vivo models, GLUTag
cells appear to respond appropriately to the regulatory mechanisms co
ntrolling intestinal GLP-1 secretion.